Related Experiment Videos

Health outcomes in pediatric rheumatic diseases

Ciaran M Duffy1

  • 1Division of Paediatric Rheumatology, Montreal Children's Hospital, Montreal, Quebec, Canada. ciaran.duffy@muhc.mcgill.ca

Current Opinion in Rheumatology
|February 11, 2004
PubMed

Insights

Pediatric rheumatic diseases show improved outcomes, but many patients still experience active disease into adulthood, leading to damage. Aggressive treatments may improve future prognoses for juvenile idiopathic arthritis and other conditions.

Area of Science:

  • Pediatric Rheumatology
  • Rheumatic Diseases Research

Background:

  • Pediatric rheumatic diseases are a significant focus of research, particularly juvenile idiopathic arthritis, juvenile dermatomyositis, and juvenile systemic lupus erythematosus.
  • Numerous studies have been published globally, with a notable concentration in North America and Europe.

Purpose of the Study:

  • To review current health outcomes in pediatric rheumatic diseases.
  • To analyze trends and identify factors influencing disease prognosis.

Main Methods:

  • Systematic review of recent research publications.
  • Analysis of health outcome data from pediatric rheumatic disease studies.

Main Results:

  • Overall outcomes have improved, yet a substantial number of individuals continue to have active disease into adulthood, resulting in damage and disability.
  • Patients with systemic arthritis and rheumatoid factor-positive polyarthritis in juvenile idiopathic arthritis face a particularly poor prognosis.

Conclusions:

  • More aggressive treatment strategies are anticipated to enhance future health outcomes.
  • Longitudinal studies with large inception cohorts are necessary to validate predictions of improved prognoses.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...